Development of a Clinical Guideline for Suicide Prevention in Psychiatric Patients Based on the ADAPTE Methodology
- Affiliations
-
- 1Department of Psychiatry, Chungnam National University Sejong Hospital, Sejong, Republic of Korea
- 2Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea
- 3Department of Preventive Medicine, Chung-Ang University College of Medicine, Seoul, Republic of Korea
- 4Department of Neuropsychiatry, Seoul National University Hospital, Seoul, Republic of Korea
- 5Department of Psychiatry, Asan Medical Center, Seoul, Republic of Korea
- 6Department of Psychiatry, Wonkwang University Hospital, Iksan, Republic of Korea
- 7Department of Psychiatry, Soon Chun Hyang University Cheonan Hospital, Soon Chun Hyang University, Cheonan, Republic of Korea
- 8Department of Psychiatry, Busan Paik Hospital, Inje University College of Medicine, Busan, Republic of Korea
- 9Department of Psychiatry, Gachon University Gil Medical Center, Incheon, Republic of Korea
- 10Department of Neuropsychiatry, Soon Chun Hyang University Bucheon Hospital, Bucheon, Republic of Korea
- 11Department of Psychiatry, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea
- 12Department of Psychiatry, Kyung Hee University Hospital, Seoul, Republic of Korea
- 13Institute of Human Behavioral Medicine, Seoul National University Medical Research Center, Seoul, Republic of Korea
Abstract
Objective
Suicide is a significant public health issue, with South Korea having the highest suicide rate among Organisation for Economic Cooperation and Development countries. This study aimed to develop clinical guidelines for suicide prevention in psychiatric patients in Korea using the ADAPTE methodology.
Methods
The development process involved a comprehensive review of literature, expert consultations, and consensus-building using the Nominal Group Technique and Delphi method. The guidelines focus on evidence-based psychiatric treatments, including both pharmacological and non-pharmacological approaches, tailored to the Korean context. Key findings underscoring the need for standardized treatment protocols for patients with major psychiatric disorders, including bipolar disorder, major depressive disorder, and schizophrenia.
Results
The guidelines incorporate treatments like lithium, clozapine, atypical antipsychotics, electroconvulsive therapy, and cognitive behavioral therapy, which have shown effectiveness in suicide prevention. Applicability and acceptability within Korea’s healthcare system were addressed, ensuring feasibility given the country’s medical insurance coverage and accessibility. The guidelines were validated through expert reviews and Delphi rounds, achieving consensus on the final recommendations.
Conclusion
The developed guidelines provide a structured, evidence-based approach to reducing suicide rates among psychiatric patients in Korea. Future research will focus on expanding these guidelines to include screening protocols for high-risk groups.